The analyses of GBM gene expression profiles from the TCGA and CGGA databases show that the prognosis of GBM patients treated with TMZ is negatively correlated with PTRF expression (Figure 1B and Figure S1B). The gene discussed is CAVIN1; the disease is glioblastoma.